Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
The Israel Medical Association Journal : IMAJ
|
July 2, 2014
Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers
David H Dreyfus, Chang Rim Na, Christopher C Randolph, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 19, 2026
High-Grade Immune-Related Adverse Events Resulting from Immune Checkpoint Inhibitor Treatment: Evaluation of Diagnostics and Outcomes in Admitted Patients
Luke P Legakis, Mridula Naagendran, Allysia Matthews, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 20, 2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity
Joel P Brooks, Veronica Azmy, Alison Thompson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
December 30, 2020
A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients
Matthew Ringer, Veronica Azmy, Kelsey Kaman, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
May 12, 2019
Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis
John George, Divyansh Bajaj, Kesavan Sankaramangalam, et al.
Journal of Clinical Immunology
|
April 3, 2020
Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum
Junghee J Shin, Daniel Liauw, Sabrina Siddiqui, et al.
The Lancet. Microbe
|
December 13, 2021
Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
Stephen Y Wang, Prerak V Juthani, Kelly A Borges, et al.
The Journal of Clinical Investigation
|
August 2, 2011
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans
Laurence Menard, David Saadoun, Isabelle Isnardi, et al.
Clinical Immunology (Orlando, Fla.)
|
May 12, 2025
Association of clinical manifestations and immune alterations with genetic variants of uncertain significance in patients concerned for inborn errors of immunity
Samantha Novotny, Noelle Yoo, Jiaye Chen, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 20, 2021
Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency
John K Kuster, Serhan Unlu, Thomas A Makin, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
The Israel Medical Association Journal : IMAJ
|
July 2, 2014
Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers
David H Dreyfus, Chang Rim Na, Christopher C Randolph, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
February 19, 2026
High-Grade Immune-Related Adverse Events Resulting from Immune Checkpoint Inhibitor Treatment: Evaluation of Diagnostics and Outcomes in Admitted Patients
Luke P Legakis, Mridula Naagendran, Allysia Matthews, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
March 20, 2019
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity
Joel P Brooks, Veronica Azmy, Alison Thompson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
December 30, 2020
A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients
Matthew Ringer, Veronica Azmy, Kelsey Kaman, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
May 12, 2019
Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis
John George, Divyansh Bajaj, Kesavan Sankaramangalam, et al.
Journal of Clinical Immunology
|
April 3, 2020
Immunological and Clinical Phenotyping in Primary Antibody Deficiencies: a Growing Disease Spectrum
Junghee J Shin, Daniel Liauw, Sabrina Siddiqui, et al.
The Lancet. Microbe
|
December 13, 2021
Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
Stephen Y Wang, Prerak V Juthani, Kelly A Borges, et al.
The Journal of Clinical Investigation
|
August 2, 2011
The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans
Laurence Menard, David Saadoun, Isabelle Isnardi, et al.
Clinical Immunology (Orlando, Fla.)
|
May 12, 2025
Association of clinical manifestations and immune alterations with genetic variants of uncertain significance in patients concerned for inborn errors of immunity
Samantha Novotny, Noelle Yoo, Jiaye Chen, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 20, 2021
Low IgG trough and lymphocyte subset counts are associated with hospitalization for COVID-19 in patients with primary antibody deficiency
John K Kuster, Serhan Unlu, Thomas A Makin, et al.
Page
of 4